Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference

RICHMOND, Va., Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37^th Annual Healthcare Conference:

• Piper Sandler 37^th Annual Healthcare Conference – New York City, NY
  
  
  
  Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, December 2^nd. Joe Ciaffoni and Ryan Preblick will also participate in a fireside discussion on Tuesday, December 2^nd at 3:30 p.m. U.S. EST. Interested investors should contact their Piper Sandler representative to schedule a meeting.
  
  
  
  The fireside discussion will be publicly available and can be viewed using the following weblink: Piper Sandler Fireside Chat Live Webcast.  

About Indivior

Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit  www.indivior.com  to learn more. Connect with Indivior on LinkedIn by visiting  www.linkedin.com/company/Indivior.

SOURCE Indivior PLC